| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |